AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
LENGTHENED ACTIVATED PARTIAL THROMBOPLAST IN TIME IN PATIENTS TREATEDWITH TINZAPARIN FOR VENOUS THROMBOEMBOLISM
Authors: ACHKAR A HORELLOU MH CONARD J LAABAN JP SAMAMA MM
Citation: A. Achkar et al., LENGTHENED ACTIVATED PARTIAL THROMBOPLAST IN TIME IN PATIENTS TREATEDWITH TINZAPARIN FOR VENOUS THROMBOEMBOLISM, La Presse medicale, 27(14), 1998, pp. 667-668
MESENTERIC VENOUS THROMBOSIS IN 2 PATIENTS HETEROZYGOUS FOR THE 20210-A ALLELE OF THE PROTHROMBIN GENE
Authors: DARNIGE L JEZEQUEL P AMOURA Z HORELLOU MH DORVAL I PIETTE JC
Citation: L. Darnige et al., MESENTERIC VENOUS THROMBOSIS IN 2 PATIENTS HETEROZYGOUS FOR THE 20210-A ALLELE OF THE PROTHROMBIN GENE, Thrombosis and haemostasis, 80(4), 1998, pp. 703-703
LOW-LEVELS OF PROTEIN-S ACTIVITY IN FACTOR-V DEPLETED PLASMA USED IN APC RESISTANCE TEST
Authors: SAMAMA MS GOUINTHIBAULT I TROSSAERT M VANDREDEN P COMBOT C AMIRAL J HORELLOU MH CONARD J
Citation: Ms. Samama et al., LOW-LEVELS OF PROTEIN-S ACTIVITY IN FACTOR-V DEPLETED PLASMA USED IN APC RESISTANCE TEST, Thrombosis and haemostasis, 80(4), 1998, pp. 715-716
CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO
Authors: ROBERT A LEQUERREC A DELAHOUSSE B CARON C HOUBOUYAN L BOUTIERE B HORELLOU MH REBER G SIE P
Citation: A. Robert et al., CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO, Thrombosis and haemostasis, 80(1), 1998, pp. 99-103
MONITORING HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESULTS OF A MULTICENTER TRIAL ESTABLISHING THE THERAPEUTIC RANGE FOR SILIMAT, A REAGENT WITH HIGH-SENSITIVITY TO HEPARIN
Authors: TOULON P BOUTIERE B HORELLOU MH TRZECIAK MC SAMAMA MM
Citation: P. Toulon et al., MONITORING HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESULTS OF A MULTICENTER TRIAL ESTABLISHING THE THERAPEUTIC RANGE FOR SILIMAT, A REAGENT WITH HIGH-SENSITIVITY TO HEPARIN, Thrombosis and haemostasis, 80(1), 1998, pp. 104-108
FREQUENCY OF THE 20210-G-]A MUTATION IN THE 3'-UNTRANSLATED REGION OFTHE PROTHROMBIN GENE IN 35 CASES OF CEREBRAL VENOUS THROMBOSIS
Authors: BIOUSSE V CONARD J BROUZES C HORELLOU MH AMERI A BOUSSER MG
Citation: V. Biousse et al., FREQUENCY OF THE 20210-G-]A MUTATION IN THE 3'-UNTRANSLATED REGION OFTHE PROTHROMBIN GENE IN 35 CASES OF CEREBRAL VENOUS THROMBOSIS, Stroke, 29(7), 1998, pp. 1398-1400
FREQUENCY OF THE 20210-G-]A MUTATION IN THE 3'-UNTRANSLATED REGION OFTHE PROTHROMBIN GENE IN 35 PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
Authors: CONARD J BROUZES C BIOUSSE V HORELLOU MH ELALAMY I CHEDRU F AMERI A SAMAMA MM BOUSSER MG
Citation: J. Conard et al., FREQUENCY OF THE 20210-G-]A MUTATION IN THE 3'-UNTRANSLATED REGION OFTHE PROTHROMBIN GENE IN 35 PATIENTS WITH CEREBRAL VENOUS THROMBOSIS, Stroke, 29(1), 1998, pp. 100-100
A SINGLE GENETIC-ORIGIN FOR THE COMMON PROTHROMBOTIC G20210A POLYMORPHISM IN THE PROTHROMBIN GENE
Authors: ZIVELIN A ROSENBERG N FAIER S KORNBROT N PERETZ H MANNHALTER C HORELLOU MH SELIGSOHN U
Citation: A. Zivelin et al., A SINGLE GENETIC-ORIGIN FOR THE COMMON PROTHROMBOTIC G20210A POLYMORPHISM IN THE PROTHROMBIN GENE, Blood, 92(4), 1998, pp. 1119-1124
ACQUIRED HEMOPHILIA DUE TO FACTOR-VIII INHIBITORS IN 34 PATIENTS
Authors: BOSSI P CABANE J NINET J DHOTE R HANSLIK T CHOSIDOW O JOUANFLAHAULT C HORELLOU MH LEYNADIER F LIOZON E POUCHOT J ROBIN JP SANDERSON F SCHAEFFER A SICARD D STAIKOWSKY F WECHSLER B ZITTOUN R
Citation: P. Bossi et al., ACQUIRED HEMOPHILIA DUE TO FACTOR-VIII INHIBITORS IN 34 PATIENTS, The American journal of medicine, 105(5), 1998, pp. 400-408
ANTIPLATELET EFFECTS OF THE ADDITION OF ACETYLSALICYLIC-ACID 40 MG DAILY TO TICLOPIDINE IN HUMAN HEALTHY-VOLUNTEERS
Authors: LECOMPTE TP LECRUBIER C BOULOUX C HORELLOU MH GALLEYRAND J MAFFRAND JP SAMAMA MM
Citation: Tp. Lecompte et al., ANTIPLATELET EFFECTS OF THE ADDITION OF ACETYLSALICYLIC-ACID 40 MG DAILY TO TICLOPIDINE IN HUMAN HEALTHY-VOLUNTEERS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 245-250
USEFULNESS OF MEASURING PLASMA D-DIMERS F OR DIAGNOSIS OF ACUTE VENOUS THROMBOEMBOLISM
Authors: LAABAN JP ACHKAR A HORELLOU MH CONARD J BOUARFA N ARKAM R LORUT C FRETAULT J VADROT D SAMAMA M ROCHEMAURE J
Citation: Jp. Laaban et al., USEFULNESS OF MEASURING PLASMA D-DIMERS F OR DIAGNOSIS OF ACUTE VENOUS THROMBOEMBOLISM, Revue des maladies respiratoires, 14(2), 1997, pp. 119-127
POLYGENIC THROMBOPHILIA - FACTOR-II GENE VARIATION AND FACTOR-V-LEIDEN MUTATION IN A FRENCH FAMILY
Authors: CONARD J MABILEAUBROUZES C HORELLOU MH ELALAMY I SAMAMA MM
Citation: J. Conard et al., POLYGENIC THROMBOPHILIA - FACTOR-II GENE VARIATION AND FACTOR-V-LEIDEN MUTATION IN A FRENCH FAMILY, La Presse medicale, 26(20), 1997, pp. 951-953
LACK OF INTEREST OF PLASMA D-DIMERS (DDI) MEASUREMENT (ELISA) IN THE PREDICTION OF THE EVOLUTION OF PULMONARY-EMBOLISM (PE)
Authors: LORUT C LAABAN JP ACHKAR A HORELLOU MH CONARD J FRETAULT J SAMAMA MM ROCHEMAURE J
Citation: C. Lorut et al., LACK OF INTEREST OF PLASMA D-DIMERS (DDI) MEASUREMENT (ELISA) IN THE PREDICTION OF THE EVOLUTION OF PULMONARY-EMBOLISM (PE), Thrombosis and haemostasis, 1997, pp. 177-177
RISK-FACTORS FOR VENOUS THROMBOEMBOLISM IN 202 WOMEN CARRIERS OF FACTOR-V-LEIDEN MUTATION AND ORAL-CONTRACEPTIVE USERS
Authors: DESMARAIS S CONARD J PLUBUREAU G HORELLOU MH ELALAMY I SAMAMA MM
Citation: S. Desmarais et al., RISK-FACTORS FOR VENOUS THROMBOEMBOLISM IN 202 WOMEN CARRIERS OF FACTOR-V-LEIDEN MUTATION AND ORAL-CONTRACEPTIVE USERS, Thrombosis and haemostasis, 1997, pp. 1525-1525
PROSPECTIVE SCREENING FOR OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: ACHKAR A LAABAN JP HORELLOU MH RABBAT A CONARD J NATAF J SAMAMA MM ROCHEMAURE J
Citation: A. Achkar et al., PROSPECTIVE SCREENING FOR OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 1564-1564
TREATMENT OF THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARINS DURING 15 PREGNANCIES IN 14 WOMEN
Authors: HORELLOU MH CONARD J ACHKAR A MISEREY G HADJEZ JM ELALAMY I SAMAMA M
Citation: Mh. Horellou et al., TREATMENT OF THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARINS DURING 15 PREGNANCIES IN 14 WOMEN, Thrombosis and haemostasis, 1997, pp. 2992-2992
ORAL CONTRACEPTION AND PREGNANCY IN 30 WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN (ACTIVATED PROTEIN-C RESISTANCE)
Authors: SAMAMA MM NASSIRI S HORELLOU MH ELALAMY I CONARD J
Citation: Mm. Samama et al., ORAL CONTRACEPTION AND PREGNANCY IN 30 WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN (ACTIVATED PROTEIN-C RESISTANCE), Thrombosis and haemostasis, 1997, pp. 3108-3108
VITAMIN-K METABOLISM IN A PATIENT RESISTANT TO VITAMIN-K ANTAGONISTS
Authors: KEREVEUR A LECLERCQ M TROSSAERT M DUPEYRON JP PARENT F HORELLOU MH CONARD J BACHMANN F SAMAMA MM
Citation: A. Kereveur et al., VITAMIN-K METABOLISM IN A PATIENT RESISTANT TO VITAMIN-K ANTAGONISTS, Haemostasis, 27(4), 1997, pp. 168-173
SEVERE LOW-MOLECULAR-WEIGHT HEPARIN-RELAT ED BLEEDINGS - 2 CASES
Authors: GRATEAU G CHAUVENET L OUDARD S BACHMEYER C CAPRON L HORELLOU MH SAMAMA MM
Citation: G. Grateau et al., SEVERE LOW-MOLECULAR-WEIGHT HEPARIN-RELAT ED BLEEDINGS - 2 CASES, La Revue de medecine interne, 18(5), 1997, pp. 411-415
LEIDEN FACTOR-V MUTATION IN 4 PATIENTS WITH SMALL-BOWEL INFARCTIONS
Authors: HERESBACH D PAGENAULT M GUERET P CRENN P HERESBACHLEBERRE N MALLEDANT Y FAUCHET R HORELLOU MH SILVER J MESSING B BRETAGNE JF
Citation: D. Heresbach et al., LEIDEN FACTOR-V MUTATION IN 4 PATIENTS WITH SMALL-BOWEL INFARCTIONS, Gastroenterology, 113(1), 1997, pp. 322-325
COMPARISON OF 2 GROUPS OF 22 AGE-MATCHED HOMOZYGOUS OR HETEROZYGOUS WOMEN
Authors: SAMAMA MM CONARD J NASSIRI S HORELLOU MH ARKAM R ELALAMY I
Citation: Mm. Samama et al., COMPARISON OF 2 GROUPS OF 22 AGE-MATCHED HOMOZYGOUS OR HETEROZYGOUS WOMEN, Bulletin de l'Academie nationale de medecine, 181(5), 1997, pp. 919-937
CONTRIBUTION OF EXTENSIVE BIOLOGICAL WORK -UP IN PATIENTS WITH VENOUSOR ARTERIAL THROMBOTIC EVENTS
Authors: TAZI Z CACOUB P KOSKAS F CHABANEL A CHADEFAUXVEKEMANS B HORELLOU MH VIARD JP PIETTE JC KIEFFER E GODEAU P
Citation: Z. Tazi et al., CONTRIBUTION OF EXTENSIVE BIOLOGICAL WORK -UP IN PATIENTS WITH VENOUSOR ARTERIAL THROMBOTIC EVENTS, La Presse medicale, 25(11), 1996, pp. 531-536
THE MODIFIED APC RESISTANCE TEST IN THE PRESENCE OF FACTOR-V DEFICIENT PLASMA CAN BE USED IN PATIENTS WITHOUT ORAL ANTICOAGULANT
Authors: TROSSAERT M CONARD J HORELLOU MH ELALAMY I SAMAMA MM
Citation: M. Trossaert et al., THE MODIFIED APC RESISTANCE TEST IN THE PRESENCE OF FACTOR-V DEFICIENT PLASMA CAN BE USED IN PATIENTS WITHOUT ORAL ANTICOAGULANT, Thrombosis and haemostasis, 75(3), 1996, pp. 521-522
DIAGNOSIS AND CLINICAL CHARACTERISTICS OF INHERITED ACTIVATED PROTEIN-C RESISTANCE
Authors: SAMAMA MM SIMON D HORELLOU MH TROSSAERT M ELALAMY I CONARD J
Citation: Mm. Samama et al., DIAGNOSIS AND CLINICAL CHARACTERISTICS OF INHERITED ACTIVATED PROTEIN-C RESISTANCE, Haemostasis, 26, 1996, pp. 315-330
COAGULATION STUDIES, FACTOR-V LEIDEN, AND ANTICARDIOLIPIN ANTIBODIES IN 40 CASES OF CEREBRAL VENOUS THROMBOSIS
Authors: DESCHIENS MA CONARD J HORELLOU MH AMERI A PRETER M CHEDRU F SAMAMA MM BOUSSER MG
Citation: Ma. Deschiens et al., COAGULATION STUDIES, FACTOR-V LEIDEN, AND ANTICARDIOLIPIN ANTIBODIES IN 40 CASES OF CEREBRAL VENOUS THROMBOSIS, Stroke, 27(10), 1996, pp. 1724-1730
Risultati: 1-25 | 26-50 | 51-72